Search for: "Janssen Pharmaceuticals Inc."
Results 141 - 160
of 248
Sort by Relevance
|
Sort by Date
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
12 Sep 2012, 6:14 pm
IPNews® - Johnson & Johnson unit Janssen Pharmaceuticals Inc. won a major patent infringement victory Tuesday when a New Jersey federal judge held that its patent for the popular birth control drug Ortho Tri-Cyclen Lo is valid. [read post]
12 Sep 2012, 6:08 pm
California -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. was vindicated Tuesday in its efforts to prevent Lupin Pharmaceuticals Inc. from making and marketing a generic version of J&J's popular birth control drug Ortho Tri-Cyclen Lo, as a New Jersey federal judge ruled that the underlying patent is valid. [read post]
7 Sep 2012, 9:41 am
Last week Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson on Thursday announced a $181 million settlement with 36 states and the District of Columbia over charges of marketing anti-psychotic drugs for non-approved uses. [read post]
2 Sep 2012, 3:20 pm
Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, agreed Thursday to pay $181 Million to settle cases brought by 36 states and the District of Columbia alleging illegal marketing of its anti-psychotic drugs for off-label, non-approved uses. [read post]
2 Sep 2012, 3:20 pm
Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, agreed Thursday to pay $181 Million to settle cases brought by 36 states and the District of Columbia alleging illegal marketing of its anti-psychotic drugs for off-label, non-approved uses. [read post]
27 Jul 2012, 12:40 pm
Cephalon, Inc., 2010 WL 1257790, at *6 (D.N.J. [read post]
13 Jul 2012, 8:02 pm
Griem, Jr. of Loeb & Loeb; Patricia Clarke Lukens, Vice President, Law at Janssen Pharmaceuticals, Inc.; and Michael Perry of the Health Care Division at the Federal Trade Commission will analyze the existing case law and pending cases and legislation, review recent trends in settlements reported to the Federal Trade Commission, and discuss in practical terms how this issue affects the conduct and resolution... [read post]
18 Jun 2012, 5:57 pm
Omnicare is currently a central player in the ongoing investigation by the Justice Department into how Johnson & Johnson’s Janssen Pharmaceuticals unit pushed the antipsychotic drug Risperdal to nursing home patients, many of whom did not have schizophrenia or bi-polar disease, which are the only ailments for which Risperdal is approved by the FDA. [read post]
17 Jun 2012, 9:55 pm
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]
23 May 2012, 9:22 pm
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
9 May 2012, 5:01 am
Circuit Judge Tim Fox determined that Johnson & Johnson and subsidiary Janssen Pharmaceuticals Inc. committed nearly 240,000 violations of the state's Medicaid fraud law — or one for each Risperdal prescription issued to state Medicaid patients over a 31/2-year period. [read post]
18 Apr 2012, 1:29 pm
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
16 Apr 2012, 9:49 pm
Cir. 2008), and Janssen Pharmaceutica, N.V. v. [read post]
16 Apr 2012, 8:26 pm
Nevertheless, Janssen Pharmaceuticals, Inc. [read post]
12 Apr 2012, 7:42 pm
Judge Tim Fox ruled that Janssen Pharmaceuticals Inc. and its parent company must pay $5,000 for each of 240,000 Risperdal prescriptions the state Medicaid program paid for during a 3½-year period. [read post]
17 Feb 2012, 11:29 am
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
24 Jan 2012, 6:34 pm
Cir. 2008) and Janssen Pharmaceutica, N.V. v. [read post]
24 Jan 2012, 8:29 am
”Janssen issued this statement:"Janssen Pharmaceuticals, Inc. announced today it has reached a settlement with the State of Texas in ongoing litigation related to sales and marketing of the anti-psychotic prescription medication Risperdal (risperidone).Read more: http://www.philly.com/philly/blogs/phillypharma/Reports-JJ-settles-with-Texas-on-Risperdal-anti-psychotic-drug-case.html#ixzz1kOU05xZ4 [read post]
22 Jan 2012, 5:42 pm
On January 19, 2012 Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, announced that it had agreed to pay $158 million to settle a Medicaid fraud lawsuit in Texas which alleged that the company improperly marketed its antipsychotic drug Risperdal causing the state to overpay for the drug. [read post]
